A gonadotropin-releasing hormone analogue impairs glucose tolerance in a diabetic patient

article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This paper describes a gonadotropin-releasing hormone analogue that impaired glucose tolerance in a diabetic patient.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Changes in serum glucose levels were examined in a female with insulin-independent diabetes who received a gonadotropin-releasing hormone (GnRH) analog treatment for pelvic endometriosis. The mean blood glucose levels were higher on busereline therapy, and higher levels of hemoglobin A1c were noted on busereline therapy (range 6.9-12.5%) versus pre- and post-treatment (range 5.1-5.9%). Hormonal alteration induced by GnRH analog treatment may impair glucose tolerance.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Blood Glucose Buserelin Diabetes Mellitus, Type 1 Endometriosis Adult Blood Glucose Buserelin Buserelin Danazol Danazol Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 1 Endometriosis Endometriosis Estrogen Antagonists Estrogen Antagonists Female Glycated Hemoglobin Glycated Hemoglobin Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (6)

Cited by (5)

Source provenance

europepmc
last seen: 2026-10-05T06:18:27.067365+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:10:46.468712+00:00
unpaywall
last seen: 2026-10-05T06:32:29.880811+00:00
License: CC0 · commercial use OK